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Nested reverse transcription–PCR 
using degenerate primers was applied 
to amplify a 222-bp fragment of the 
large RNA segment of phleboviruses 
(9). The retrieved sequence was 
identical to sequences detected in 
sandfl ies collected in 2005 in the 
Adriatic coastal region of Albania; 
that strain was provisionally named 
Adria virus (10). Adria virus is distinct 
from other recognized members of 
the genus Phlebovirus and clusters 
with phleboviruses of the Salehabad 
serocomplex, such as Salehabad virus 
and Arbia virus, differing by 21.6% 
and 29.6% with Salehabad virus and 
Arbia virus at the nucleotide level and 
by 3% and 17.7% at the amino acid 
level, respectively (Table).
Detection of the Adria virus 
sequence in the patient’s blood 
suggests that this virus is pathogenic 
to humans. As expected, serologic 
testing of the sample taken at the time 
of admission produced negative results 
for phleboviruses; a convalescent-
phase blood sample was not available. 
Although the course of the disease in 
the child was mild, further studies will 
show the role of this strain in public 
health.
Because the duration of viremia 
in persons with phlebovirus infections 
is short, use of molecular methods for 
the laboratory diagnosis of phleboviral 
infections is limited; and even when 
a phleboviral infection is confi rmed 
by serologic testing, the exact strain 
is diffi cult to determine. Physicians 
in Greece, as in other Mediterranean 
countries, should be aware of the 
circulation of phleboviruses and 
potential risk for phlebovirus-
associated infections during the 
summer. Such infections, especially 
with neurologic signs, should be 
included in the differential diagnosis 
of summer febrile syndromes.
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Seroprevalence  
of Toscana Virus 
in Blood Donors, 
France, 2007
To the Editor: Toscana virus 
(TOSV) is an arthropod-borne RNA 
virus (family Bunyaviridae and 
genus Phlebovirus) transmitted by 
sandfl ies in Mediterranean countries. 
TOSV causes acute meningitis and 
meningoencephalitis in patients. In 
France, cases of TOSV infections 
involving resident populations and 
cases imported by tourists traveling 
in TOSV-endemic countries have 
been reported (1,2); the virus has also 
been isolated from local wild-caught 
sandfl ies (1). The fact that TOSV 
has been isolated from human blood 
on several occasions (2) suggests a 
potential risk exists for transmitting 
the virus through blood transfusion or 
organ transplantation. We investigated 
the presence of TOSV antibodies in 
a sample of the healthy population, 
blood donors from southeastern 
France.
We tested plasma collected 
from 729 blood donors in 7 French 
territorial divisions during the 
summer of 2007. Plasma donors were 
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analyzed according to their address of 
residence in each territorial division. 
Information related to these donors is 
reported in the Table.
Presence of immunoglobulin 
(Ig) G and IgM against TOSV was 
investigated by using a commercial 
enzyme immunoassay kit (EIA 
Enzywell Toscana virus IgG and 
IgM; DIESSE Diagnostica Senese 
S.p.A., Siena, Italy) developed by 
using the recombinant nucleocapsid 
(N) protein of TOSV. This serologic 
test was validated in a previous study 
that revealed high specifi city and 
sensitivity (3).
Our results showed that 84 
(11.5%) of 729 plasma samples were 
positive for IgG against TOSV N 
protein. Twenty-four (3.3%) plasma 
samples were positive for IgM, and 5 
(0.7%) were positive for IgG and IgM 
(Table).
To confi rm the ELISA results, 
IgG-positive samples were further 
subjected to Western blot (WB) 
analysis by using TOSV (isolate H/
IMTSSA [2])–infected cell lysate 
(4). In 233 (32%) of samples, we 
detected a protein of molecular mass 
compatible with that of the N protein. 
A previously reported antibody-
positive control was used to validate 
the WB assay (5). Our WB analysis 
showed a reduced sensitivity when 
compared with results of ELISA. 
After chemical/heat treatment of the 
protein samples, WB will only detect 
the linear epitopes on the N protein, 
while ELISA detects both linear and 
conformational epitopes. Furthermore, 
a less recent exposure of the blood 
donor population to the virus would 
have resulted in weaker N protein 
detection by WB as a consequence of 
a lower antibody titer. However, we 
cannot exclude some aspecifi c cross-
reactivity as a consequence of well-
conserved N protein sequence among 
the genus.
Finally, to detect TOSV RNA, 
we processed IgM-positive plasma 
samples by reverse transcription–PCR 
(6). The fi nding of IgM is an indication 
of a recent exposure to the virus and 
hence a possible presence in blood. 
Our PCR did not detect any viral 
RNA in the samples. Such negative 
results could indicate either cleared 
viremia or a low viral load, below the 
sensitivity limit of the test.
Serologic information obtained 
in our study confi rms the circulation 
of TOSV in southeastern France. 
Factors such as commercial exchange 
and movement of humans, animals, 
and arthropods between France 
and Italy may explain the highest 
prevalence observed (18.8%) in the 
Alpes Maritimes territorial district, 
which borders Italy. Our results 
regarding this area appear of the same 
order of magnitude as those reported 
in the general Italian population 
(>20%) (1).
Geographic and climatic con-
ditions (e.g., temperature, humidity), 
factors that affect vector distribution 
and abundance (7), could explain 
the lower prevalence found in the 
mountainous districts (collectively 
≈400–2,000 meters in elevation). The 
lower temperatures in these districts 
may also affect the ability of vectors 
to effi ciently transmit the virus in the 
fi eld (8).
TOSV prevalence in Corsica, an 
island in the Mediterranean Sea, was 
unexpectedly high. In this region, 
≈8.7% (10 donors of 115) of the 
population sampled showed an IgG- 
or IgM-positive response. In the other 
districts, the IgM seroprevalence 
did not exceed 4.4%. The vector 
that transmits TOSV is known to be 
present in this area (7), and TOSV 
infections have been reported on 
nearby Sardinia (9). The elevated IgM 
titer in the population in Corsica could 
indicate 1) recent virus contacts; 2) 
recent infections with a new TOSV 
strain circulating in Corsica; or 3) 
presence of related phleboviruses that 
are inducing cross-reactivity in the N 
protein–based IgM ELISA.
Our results demonstrate that 
14.1% (IgG and IgM) of  the healthy 
population (blood donors) in France 
living on the Mediterranean border 
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Table.  Prevalence of antibodies against Toscana virus in blood donors, France, 2007* 
Demographic characteristic No. donors 
% IgG-positive 
samples 
% IgM-positive 
samples 
Age, y 
 <30 211 11.8 3.8
 30–39 133 11.3 3
 40–49 156 11.5 2.6
 50–60 158 10.8 4.4
 >60 71 12.7 1.4
Sex
 F 353 13.9 2.5
 M 376 9.3 4
French territorial division† 
 Alpes de Haute Provence 29 10.3 3.4
 Hautes Alpes 64 6.25 1.6
 Alpes Maritime 111 19 0
 Bouches du Rhône  143 12.6 2.8
 Corsica  115 8.7 8.7
 Var 154 8.4 1.9
 Vaucluse 113 13.3 4.4
Total 729 11.5 3.3
*Plasma samples were determined as positive by using an ELISA to detect immunoglobulin (Ig) G 
against Toscana virus (absorbance cutoff value [optical density at 450 nm (OD450)]>0.47) and IgM 
(absorbance cutoff value of OD450>0.15). Mean age of seropositive blood donors were the following: 
women, 40 y (SD 13.73 y); men, 41.8 y (SD 13.71 y). 
†French territorial division elevations: Alpes de Haute Provence, 280–3,412 m; Hautes Alpes, 430–
4,101 m; Alpes Maritimes, 0–3,143 m; Bouches du Rhône, –2–1,042 m; Corsica, 0–2,706 m; Var, 
0–1,714 m; Vaucluse, 12–1,909 m. 
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have been in contact with TOSV 
and show asymptomatic or mild, 
unidentifi ed symptoms, as it is the case 
for many other arbovirus infections 
(10). Such fi ndings raise concerns 
about the risks of virus transmission 
to virus-naive persons by blood 
transfusions and organ transplants.
Further investigation is needed to 
better assess how widespread TOSV 
is in populations. For example, a 
donor–recipient investigation might 
confi rm virus transmission by blood 
transfusion, and studies related to 
the behavior of sandfl y vectors, virus 
biology, and mammalian reservoir 
hosts could help defi ne populations at 
higher risk for exposure.
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Quinine-Resistant 
Malaria in 
Traveler Returning 
from French 
Guiana, 2010
To the Editor: Resistance of 
Plasmodium falciparum to antimalarial 
drugs is one of the most worrying 
problems in tropical medicine. For 
P. falciparum malaria acquired in 
French Guiana, the combination of 
quinine and doxycycline is one of the 
fi rst-line recommended treatments 
(1). Since 1996, only 2 treatment 
failures with quinine have been 
reported from that country (2). An 
elevated 50% inhibitory concentration 
(IC50), classifi ed as in vitro quinine 
resistance, was reported for 17% of 32 
P. falciparum isolates obtained during 
1983–1987 in French Guiana (3). 
Throughout 1994–2005, isolates were 
susceptible to quinine, with a mean 
IC50 <200 nmol/L (4).
We report quinine treatment 
failure in a 35-year-old man who was 
infected during a 3-month stay in 
Saül, a rural area of French Guiana. 
The patient did not use antivectorial or 
antimalarial prophylaxis. The patient 
sought treatment with fever 4 days 
after returning to France on June 22, 
2010 (day 0), and a diagnosis of P. 
falciparum malaria was made on the 
basis of results of a rapid diagnostic 
test performed by a private medical 
laboratory. The man, who weighed 
58 kg, was treated as an outpatient 
with 500 mg of quinine to be taken 
orally 3×/d for 7 days; he did not 
receive doxycycline. He was admitted 
to the Laveran Military Teaching 
Hospital in Marseille on July 15 (day 
24 and fi rst day of recrudescence) 
for uncomplicated malaria with a P. 
falciparum parasitemia level of 4%. 
He was given artemether, 80 mg/d, 
by intramuscular injection for 3 
days. Blood samples taken on day 27 
(third day of recrudescence) and day 
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